Key result
Immunosuppressive therapy is linked to the development of hyperlipidemia.
Key points are not available for this paper at this time.
Design
Other
May warrant lipid monitoring in immunosuppressed patients; leaves open causality and management needs.
aANZAC Research Institute bDepartment of Cardiology, Concord Repatriation General Hospital; University of Sydney, Sydney, New South Wales, Australia Correspondence to Leonard Kritharides, Department of Cardiology, Concord Repatriation General Hospital, University of Sydney, Concord, Sydney, NSW 2139, Australia. Tel: +61 2 9767 6296; fax: +61 2 9767 6994; e-mail: [email protected]
No takes yet. Share an insight, caveat, or question.
Kockx et al. (2016) studied this question. Immunosuppressive therapy is associated with the development of hyperlipidaemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: